SCHEMBL2786006

SCHEMBL2786006

CCCC(C)NCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
CHRM1 P11229 1/20 0.41
AKR1A1 P14550 1/20 0.41
CHRM3 P20309 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
PTGS2 P35354 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20377970 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ETDP1HDAC1HDAC2
SCHEMBL20377966 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ETDP1HDAC1HDAC2
SCHEMBL16267383 0.98 ALDH1A1 (0.43) ALDH1A1KDM4ETDP1HDAC1HDAC2
SCHEMBL246200 0.87 CA2 (0.42) FAAHPLA2G2A
SCHEMBL5595513 0.85 FAAH (0.47) MAPTACE2FAAHPLA2G2A
SCHEMBL5595510 0.85 FAAH (0.47) MAPTACE2FAAHPLA2G2A
SCHEMBL5595691 0.85 FAAH (0.47) MAPTACE2FAAHPLA2G2A
SCHEMBL7082285 0.84 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1HDAC1HDAC2
SCHEMBL6670003 0.84 FAAH (0.50) ALDH1A1TDP1MAPTACE2FAAH
Hydrochloric Acid SCHEMBL5596139 0.84 FAAH (0.46) MAPTACE2FAAHPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025038979-A1 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND/OR TREATMENT OF AMYLOID B PEPTIDE PROTEINOPENIA IN ALZHEIMER'S AND OTHER DISEASES LVIS-Regain LP (US) 2025-02-20 WO claimed
EP-3328877-B1 PEPTOID THE UNIV OF DURHAM (GB) 2022-08-24 EP claimed
US-20180201647-A1 Peptoid THE UNIVERSITY OF DURHAM (GB) 2018-07-19 US claimed
WO-2025038979-A1 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND/OR TREATMENT OF AMYLOID B PEPTIDE PROTEINOPENIA IN ALZHEIMER'S AND OTHER DISEASES LVIS-Regain LP (US) 2025-02-20 WO disclosed
US-20230292741-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES X-THERMA, INC. (US) 2023-09-21 US disclosed
US-11564388-B2 Supercooling methods for preservation of biological samples X-THERMA, INC. (US) 2023-01-31 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-3328877-B1 PEPTOID THE UNIV OF DURHAM (GB) 2022-08-24 EP disclosed
US-20200239632-A1 NOVEL PEPTOID POLYMERS AND METHODS OF USE X-THERMA, INC. (US) 2020-07-30 US disclosed
US-20200170241-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES X-THERMA, INC. (US) 2020-06-04 US disclosed
US-20180201647-A1 Peptoid THE UNIVERSITY OF DURHAM (GB) 2018-07-19 US disclosed
WO-2006089364-A1 PEPTIDE NETWORKS THE UNIVERSITY OF QUEENSLAND (AU) 2006-08-31 WO disclosed
WO-2006079176-A1 MOLECULES AND CHIMERIC MOLECULES THEREOF APOLLO LIFE SCIENCES LIMITED (AU) 2006-08-03 WO disclosed
WO-2006026820-A1 TREATING GLIOSIS, GLIAL SCARRING, INFLAMMATION OR INHIBITION OF AXONAL GROWTH IN THE NERVOUS SYSTEM BY MODULATING EPH RECEPTOR THE UNIVERSITY OF QUEENSLAND (AU) 2006-03-16 WO disclosed
EP-1597350-A2 NUCLEIC ACID MOLECULES, POLYPEPTIDES, ANTIBODIES AND COMPOSITIONS CONTAINING SAME USEFUL FOR TREATING AND DETECTING INFLUENZA VIRUS INFECTION YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) 2005-11-23 EP disclosed
EP-1315752-A4 MODIFIED PROTEINS, ISOLATED NOVEL PEPTIDES, AND USES THEREOF UNIV AUSTRALIAN (AU) 2005-07-06 EP disclosed
WO-2004076621-A2 COMPOSITIONS OF NUCLEIC ACIDS FOR TREATING AND DETECTING INFLUENZA VIRUS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2004-09-10 WO disclosed
EP-1315752-A1 MODIFIED PROTEINS, ISOLATED NOVEL PEPTIDES, AND USES THEREOF THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-06-04 EP disclosed
WO-2002018438-A1 MODIFIED PROTEINS, ISOLATED NOVEL PEPTIDES, AND USES THEREOF THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2002-03-07 WO disclosed
US-4581209-A N-aminoalkyl alkylpiperazine promoted acid gas scrubbing process EXXON RESEARCH AND ENGINEERING CO. (US) 1986-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200170241-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES PPIG, AQP3, AQP1 ALDH1A1 4823/4885KDM4E 4077/4885TDP1 888/4885
US-11564388-B2 Supercooling methods for preservation of biological samples PPIG, AQP3, PYGB ALDH1A1 4840/4885KDM4E 4094/4885TDP1 939/4885
US-20180201647-A1 Peptoid ARG1, ARGLU1, QPCT ALDH1A1 4876/4885KDM4E 810/4885TDP1 2235/4885
US-20200239632-A1 NOVEL PEPTOID POLYMERS AND METHODS OF USE CUTA, IAPP, CRYAA ALDH1A1 4562/4885KDM4E 4618/4885TDP1 1657/4885
US-20230292741-A1 NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES PPIG, AQP3, AQP1 ALDH1A1 4823/4885KDM4E 4077/4885TDP1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.